Abbott Laboratories (ABT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Abbott Laboratories (ABT:NYSE), powered by AI.

Current Price
$90.62
P/E Ratio
24.1
Market Cap
157.4B
Sector
Healthcare
What is the Abbott Laboratories stock price forecast?

Abbott Laboratories is currently trading at $90.62. View real-time AI analysis on Alpha Lenz.

What is Abbott Laboratories insider trading activity?

View the latest insider trading data for Abbott Laboratories on Alpha Lenz.

What is Abbott Laboratories's P/E ratio?

Abbott Laboratories's P/E ratio is 24.1.

Abbott Laboratories

NYSE · ABT
$90.62+1.95(+2.20%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Abbott Laboratories's future dividend policy...
Alpha Chat Insight

Abbott Laboratories trades at a P/E of 24.1 (fair value) with solid ROE of 13.1%.

Ask for details

Company Overview

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.

CEOMr. Robert B. Ford
SectorHealthcare
IndustryMedical Devices
Employees114,000

Company Statistics

FY 2025

Profile

$157.37BMarket Cap
$44.33BRevenue
0.00Shares Out
114,000Employees

Margins

56.42%Gross
27.13%EBITDA
18.17%Operating
19.10%Pre-Tax
14.72%Net

Valuation

24.12P/E
3.02P/B
3.55EV/Sales
13.58EV/EBITDA
21.28P/FCF

Growth (CAGR)

0.51%Rev 3Yr
5.08%Rev 5Yr
-1.25%Op Inc 3Yr
8.49%Op Inc 5Yr
-2.01%Net Inc 3Yr
7.74%Net Inc 5Yr

Returns

7.76%ROA
13.07%ROE
10.66%ROIC

Financial Health

$8.52BCash & Cash Equivalents
$25.42BNet Debt
64.32%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Abbott Laboratories (ticker: ABT) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 114,000 employees. Market cap is $157.4B.

The current price is $90.62 with a P/E ratio of 24.12x and P/B of 3.02x.

ROE is 13.07% and operating margin is 18.17%. Annual revenue is $44.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Abbott Laboratories (ABT) Stock Forecast 2026 $90.62 — Price, Financials & Analyst Targets | Alpha Lenz